Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis MEDS

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History MEDS

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – SEK
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends 0
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.
Financial Score
Dividend Policy i

Sales Growth MEDS

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin MEDS

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income MEDS

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM MEDS

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio MEDS

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Meds Apotek AB MEDS

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself MEDS

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 54.36
Forward PE
Enterprise Value Revenue 0.32
Price Sales TTM 0.38
Enterprise Value EBITDA 19.00
Price Book MRQ 2.95

Meds Apotek AB

MEDS
Current price
21.80 SEK -0.1 SEK (-0.46%)
Last closed 21.20 SEK
ISIN unknown
Sector Consumer Cyclical
Industry Internet Retail
Exchange Stockholm Exchange
Capitalization 395 321 755 SEK
Yield for 12 month -62.41 %
1Y
3Y
5Y
10Y
15Y
MEDS
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+1 010 461 156 SEK

Last Year

+832 577 993 SEK

Current Quarter

+271 030 181 SEK

Last Quarter

+258 686 484 SEK

Current Year

+279 309 515 SEK

Last Year

+232 928 782 SEK

Current Quarter

+75 289 117 SEK

Last Quarter

+68 989 759 SEK
EBITDA -660 658 SEK
Operating Margin TTM 1.92 %
Price to Earnings 54.36
Return On Assets TTM
PEG Ratio
Return On Equity TTM 7.88 %
Wall Street Target Price 462.54 SEK
Revenue TTM 1 038 615 491 SEK
Book Value 7.23 SEK
Revenue Per Share TTM 57.87 SEK
Dividend Share
Quarterly Revenue Growth YOY 11.60 %
Dividend Yield
Gross Profit TTM 234 411 751 SEK
Earnings per share 0.39 SEK
Diluted Eps TTM 0.39 SEK
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY -12.90 %
Profit Margin 0.73 %
Price to Free Cash Flow TTM 22.47

Technical Indicators MEDS

For 52 Weeks

20.88 SEK 77.31 SEK
50 Day MA 23.68 SEK
Shares Short Prior Month
200 Day MA 39.58 SEK
Short Ratio
Shares Short
Short Percent